Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion

Molecular Nutrition and Food Research

Volumn 59, Issue 7, 2015, Pages 1264-1273

  Tsuda, Takanori ^a  

^a CHUBU UNIVERSITY   (Japan)

Author keywords

Diabetes; Dietary factors; Glucagon like peptide 1; Incretin; Nutrients

Indexed keywords

AMINO ACID; CURCUMIN; GLUCAGON LIKE PEPTIDE 1;

DIABETES MELLITUS, TYPE 2; DIET; DIET THERAPY; DIETARY SUPPLEMENT; HUMAN; LIPID METABOLISM; METABOLISM; MOLECULARLY TARGETED THERAPY; SECRETION (PROCESS); SWEET POTATO;

AMINO ACIDS; CURCUMIN; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENTS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; IPOMOEA BATATAS; LIPID METABOLISM; MOLECULAR TARGETED THERAPY;

EID: 84934437784     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400871     Document Type: Review

References (79)

1. Scully, T., Diabetes in numbers. Nature 2012, 485, S2-S3.
2. Lovshin, J. A, Drucker, D. J., Incretin-based therapies for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2009, 5, 262-269.
3. Baggio, L. L, Drucker, D. J., Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132, 2131-2157.
4. Campbell, J. E., Drucker, D. J., Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013, 17, 819-837.
5. Herman, G. A., Bergman, A., Stevens, C., Kotey, P. et al., Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 2006, 91, 4612-4619.
6. Pilichiewicz, A., O'Donovan, D., Feinle, C., Lei, Y. et al., Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2003, 88, 3829-3834.
7. Ma, J., Stevens, J. E., Cukier, K., Maddox, A. F. et al., Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009, 32, 1600-1602.
8. Dalgaard, M., Thomsen, C., Rasmussen, B. M., Holst, J. J. et al., Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients. Metabolism 2004, 53, 77-83.
9. Carrel, G., Egli, L., Tran, C., Schneiter P. et al., Contributions of fat and protein to the incretin effect of a mixed meal. Am. J. Clin. Nutr. 2011, 94, 997-1003.
10. Iwasaki, M., Hoshian, F., Tsuji, T., Hirose, N. et al., Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels. J. Diabetes. Invest. 2012, 3, 464-467.
11. Reimann, F., Williams . L., Silva, da., Xavier, G., Rutter, G. A. et al., Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 2004, 47, 1592-1601.
12. 2+ and cAMP. Endocrinology 2011, 152, 405-413.
13. Samocha-Bonet, D., Wong, O., Synnott, E. L., Piyaratna, N. et al., Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. J. Nutr. 2011, 141, 1233-1238.
14. Clemmensen, C., Smajilovic, S., Smith, E. P., Woods, S. C. et al., Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice. Endocrinology 2013, 154, 3978-3983.
15. Greenfield, J. R., Farooqi, I. S., Keogh, J. M., Henning, E. et al., Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am. J. Clin. Nutr. 2009, 89, 106-113.
16. Oya, M., Kitaguchi, T., Pais, R., Reimann, F. et al., The G protein-coupled receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secretion from GLUTag cells. J. Biol. Chem. 2013, 288, 4513-4521.
17. Chen, Q., Reimer, R. A. Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 2009, 25, 340-349.
18. Geraedts, M. C., Troost, F. J., Fischer, M. A., Edens, L. et al., Direct induction of CCK and GLP-1 release from murine endocrine cells by intact dietary proteins. Mol. Nutr. Food Res. 2011, 55, 476-484.
19. Hira, T., Mochida, T., Miyashita, K., Hara, H. GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297, G663-G671.
20. Mochida, T., Hira, T., Hara H. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 2010, 151, 3095-3104.
21. Higuchi, N., Hira, T., Yamada, N., Hara, H. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats. Endocrinology 2013, 154, 3089-3098.
22. Reimer, R. A. Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. J. Endocrinol. 2006, 191, 159-170.
23. Diakogiannaki, E., Pais, R., Tolhurst, G., Parker, H. E. et al., Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia 2013, 56, 2688-2696.
24. Zhang, J., Xue, C., Zhu, T., Vivekanandan, A. et al., A tripeptide Diapin effectively lowers blood glucose levels in male type 2 diabetes mice by increasing blood levels of insulin and GLP-1. PLoS One 2013, 8, e83509.
25. Civelli, O. GPCR deorphanizations: the novel, the known and the unexpected transmitters. Trends. Phamacol. Sci. 2005, 26, 15-19.
26. Parker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M. et al., Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 2009, 52, 289-298.
27. Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E. et al., Glucose sensing in L cells: a primary cell study. Cell Metab. 2008, 8, 532-539.
28. Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S. et al., Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 2005, 11, 90-94.
29. Tanaka, T., Yano, T., Adachi, T., Koshimizu, T. A. et al., Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells. Naunyn. Schmiedebergs Arch. Pharmacol. 2008, 377, 515-522.
30. Paulsen, S. J., Larsen, L. K., Hansen, G., Chelur, S. et al., Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion. PLoS One 2014, 9, e88227.
31. Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G. et al., The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 2003, 278, 11303-11311.
32. Edfalk, S., Steneberg, P., Edlund, H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 2008, 57, 2280-2287.
33. Hara, T., Hirasawa, A., Ichimura, A., Kimura, I. et al., Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J. Pharm. Sci. 2011, 100, 3594-3601.
34. Rodríguez de Fonseca, F., Navarro, M., Gómez, R., Escuredo, L. et al., An anorexic lipid mediator regulated by feeding. Nature 2001, 414, 209-212.
35. Lauffer, L. M., Iakoubov, R., Brubaker, P. L., GPR119 is essential for oleoylethanolamide induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L cell. Diabetes 2009, 58, 1058-1066.
36. Iakoubov, R., Izzo, A., Yeung, A., Whiteside, C. I. et al., Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 2007, 148, 1089-1098.
37. Katsuma, S., Hirasawa, A., Tsujimoto, G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 2005, 329, 386-390.
38. Thomas, C., Gioiello, A., Noriega, L., Strehle, A. et al., TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009, 10, 167-177.
39. Kuhre, R.E., Gribble, F. M., Hartmann, B., Reimann, F. et al., Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306, G622-G630.
40. Hira, T., Muramatsu, M., Okuno, M., Hara, H. GLP-1 secretion in response to oral and luminal palatinose (isomaltulose) in rats. J. Nutr. Sci. Vitaminol. 2011, 57, 30-35.
41. Maeda, A., Miyagawa, J., Miuchi, M., Nagai, E. et al., Effects of the naturally-occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non-obese subjects. J. Diabetes Investig. 2013, 4, 281-286.
42. Moriya, R., Shirakura, T., Ito, J., Mashiko, S. et al., Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E1358-E1365.
43. Wu, T., Zhao, B. R., Bound, M. J., Checklin, H. L. et al., Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans. Am. J. Clin. Nutr. 2012, 95, 78-83.
44. Delzenne, N. M., Cani, P. D., Neyrinck, A. M. Modulation of glucagon-like peptide-1 and energy metabolism by inulin and oligofructose: experimental data. J. Nutr. 2007, 137, 2547S-2551S.
45. Parnell, J. A., Reimer, R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009, 89, 1751-1759.
46. Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1160-E1166.
47. Bodinham, C. L., Al-Mana, N. M., Smith, L., Robertson, M. D. Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption. Br. J. Nutr. 2013, 110, 1429-1433.
48. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E. et al., Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012, 61, 364-371.
49. Kaji, I., Karaki, S., Kuwahara, A. Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion 2014, 89, 31-36.
50. Yu, Y., Liu, L., Wang, X., Liu, X. et al., Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem. Pharmacol. 2010, 79, 1000-1006.
51. Huang, T. N., Lu, K. N., Pai, Y. P., Chin, Hsu. et al., Role of GLP-1 in the hypoglycemic effects of wild bitter gourd. Evid. Based Complement. Alternat. Med. 2013, 2013, 625892.
52. Dao, T. M., Waget, A., Klopp, P., Serino, M. et al., Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS One 2011, 6, e20700.
53. González-Abuín, N., Martínez-Micaelo, N., Margalef, M., Blay, M. et al., A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. Food Funct. 2014, 5, 2357-2364.
54. González-Abuín, N., Martínez-Micaelo, N., Blay, M., Green, B. D. et al., Grape-seed procyanidins modulate cellular membrane potential and nutrient-induced GLP-1 secretion in STC-1 cells. Am. J. Physiol. Cell Physiol. 2014, 306, C485-C492.
55. González-Abuín, N., Martínez-Micaelo, N., Blay, M., Ardévol, A. et al., Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production. J. Agric. Food Chem. 2014, 62, 1066-1072.
56. Phuwamongkolwiwat, P., Hira, T., Hara, H. A nondigestible saccharide, fructooligosaccharide, increases the promotive effect of a flavonoid, α-glucosyl-isoquercitrin, on glucagon-like peptide 1 (GLP-1) secretion in rat intestine and enteroendocrine cells. Mol. Nutr. Food Res. 2014, 58, 1581-1584.
57. Liu, C. Y., Huang, C. J., Huang, L. H., Chen, I. J. et al., Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLOS One 2014, 9, e91163.
58. Törrönen, R., Sarkkinen, E., Niskanen, T., Tapola, N. et al., Postprandial glucose, insulin and glucagon-like peptide 1 responses to sucrose ingested with berries in healthy subjects. Br. J. Nutr. 2012, 107, 1445-1451.
59. Hoggard, N., Cruickshank, M., Moar, K. M., Bestwick, C. et al., A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36% wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle. J. Nutr. Sci. 2013, 2, e22.
60. van Dam, R. M., Hu, F. B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005, 294, 97-104.
61. Huxley, R., Lee, C. M., Barzi, F., Timmermeister, L. et al., Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch. Intern. Med. 2009, 169, 2053-2063.
62. Mostofsky, E., Rice, M. S., Levitan, E. B., Mittleman, M. A. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ. Heart Fail. 2012, 5, 401-405.
63. McCarty, M. F. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med. Hypotheses 2005, 64, 848-853.
64. Johnston, K. L, Clifford, M. N., Morgan, L. M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am. J. Clin. Nutr. 2003, 78, 728-733.
65. Tunnicliffe, J. M., Shearer, J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl. Physiol. Nutr. Metab. 2008, 33, 1290-1300.
66. Rafferty, E. P., Wylie, A. R., Elliott, C. T., Chevallier, O. P. et al., In vitro and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (GLP-1). Sci. Pharm. 2011, 79, 615-621.
67. Olthof, M. R., van Dijk, A. E., Deacon, C. F., Heine, R. J. et al. Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. Nutr. Metab. 2011, 8, 10.
68. Sangle G. V., Lauffer, L. M., Grieco, A., Trivedi, S. et al., Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue. Endocrinology 2012, 153, 564-573.
69. 2+/calmodulin-dependent kinase II activation. Biochem. Biophys. Res. Commun. 2013, 435, 165-170.
70. Chuengsamarn, S., Rattanamongkolgul, S. R., Luechapudiporn, R., Phisalaphong, C. et al., Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012, 35, 2121-2127.
71. 2+/calmodulin kinase II (CaMK II) in genistein-induced potentiation of leucine/glutamine-stimulated insulin secretion. Mol. Cells 2009, 28, 167-174.
72. 2+, CaMKII and PKA in EGb 761-induced insulin secretion in INS-1 cells. J. Ethnopharmacol. 2007, 110, 49-55.
73. Dixit, S. S., Wang, T., Manzano, E. J., Yoo, S. et al., Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance. PLoS One 2013, 8, e58655.
74. Janssen, S., Depoortere, I. Nutrient sensing in the gut: new roads to therapeutics? Trends Endocrinol. Metab. 2013, 24, 92-100.
75. Kurata, R., Adachi, M., Yamakawa, O., Yoshimoto M. Growth suppression of human cancer cells by polyphenolics from sweetpotato (Ipomoea batatas L.) leaves. J. Agric. Food Chem. 2007, 55, 185-190.
76. Nagai, M., Tani, M., Kishimoto, Y., Iizuka, M. et al., Sweet potato (Ipomoea batatas L.) leaves suppressed oxidation of low density lipoprotein (LDL) in vitro and in human subjects. J. Clin. Biochem. Nutr. 2011, 48, 203-208.
77. Nagamine, R., Ueno, S., Tsubata, M., Yamaguchi, K., et al., Dietary sweet potato (Ipomoea batatas L.) leaf extract attenuates hyperglycaemia by enhancing the secretion of glucagon-like peptide-1 (GLP-1). Food Funct. 2014, 5, 2309-2316.
78. Shirazi-Beechey, S. P., Daly, K., AI-Rammahi, M., Moran, A. W. et al., Role of nutrient-sensing taste 1 receptor (T1R) family members in gastrointestinal chemosensing. Br. J. Nutr. 2014, 111 (Suppl 1), S8-S15.
79. Li, S. K., Zhu, D., Gaisano, H. Y., Brubaker, P. L. Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell. Diabetologia 2014, 57, 809-818.